Cue Biopharma, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
CUE on Nasdaq
Location
40 Guest Street, Boston, MA

There are no Buy or Sell transactions made by insiders since 11/5/2023

Cue Biopharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Michael J. Fox Director $3.04M Jun 5, 2024
Cameron Gray Director $1.9M Jun 14, 2022
Anish Suri President And Cso $374K Jun 5, 2024
Daniel Passeri CHIEF EXECUTIVE OFFICER, Director $371K Mar 6, 2024
Patrick Verheyen Director $22.6K Jan 2, 2024
Peter Kiener Director $985 Jan 2, 2024
Colin Sandercock Svp, General Counsel Jun 5, 2024
Matteo Levisetti Chief Medical Officer Jun 5, 2024
Pamela Garzone Director Jan 2, 2024
Frederick Driscoll Director Jan 2, 2024
Tamar Howson Director Jan 3, 2023
Kenneth Pienta Chief Medical Officer Mar 25, 2022
Lucinda Warren Chief Business Officer Sep 3, 2024
Aaron G.L. Fletcher Director Jan 3, 2023
Patricia Nasshorn Chief Business Officer Feb 16, 2023
Kerri-Ann Millar Chief Financial Officer Jun 5, 2024
Frank Morich Director Jan 2, 2024

Recent Insider Transactions by Companies or Individuals for Cue Biopharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.